Healthcare Cost Containment and Tighter Approval Standards in Developed Markets
First written in FY2016-Q3. 11 of 12 entries say "Restated". Latest entry: FY2023.
The whole theme swung hardest in 2018: 20 of 65 companies on the "Worse" side.
47 other companies' latest entry also says "Restated".
- FY2023RestatedAnnual report
「As population aging and advances in medical technology drive a sharp increase in healthcare spending, developed countries are introducing healthcare cost-containment policies one after another.」
The external environment is again described as one in which policies to contain healthcare spending in developed countries will continue. - FY2021RestatedAnnual report
「As population aging and advances in medical technology drive a sharp increase in healthcare spending, developed countries are introducing healthcare cost-containment policies one after another.」
The external environment is again assessed as one in which policies to contain healthcare spending in developed countries will continue. - FY2018RestatedAnnual report
「As population aging and advances in medical technology drive a sharp increase in healthcare spending, developed countries are introducing healthcare cost-containment policies one after another.」
The view that policies to contain healthcare spending in developed countries and challenging conditions in the medical device industry will continue is reaffirmed. - FY2018-Q3RestatedAnnual report
「Although advanced economies continue to face challenging conditions, including policies to contain healthcare spending and tighter approval standards」
The challenging business environment in developed countries resulting from policies to contain healthcare spending and tighter approval standards continues to be cited. - FY2018-Q2RestatedAnnual report
「Although advanced economies continue to face challenging conditions, including policies to contain healthcare spending and tighter approval standards」
The challenging business environment in developed countries resulting from policies to contain healthcare spending and tighter approval standards continues to be cited. - FY2018-Q1RestatedAnnual report
「Although advanced economies continue to face challenging conditions, including policies to contain healthcare spending and tighter approval standards」
The company continues to describe the challenging environment in advanced economies resulting from healthcare spending controls and tighter approval standards. - FY2017RestatedAnnual report
「As population aging and advances in medical technology drive a sharp increase in healthcare spending, developed countries are introducing healthcare cost-containment policies one after another.」
The view is presented that policies to contain healthcare spending and challenging conditions in the medical device industry will continue. - FY2017-Q3RestatedAnnual report
「Although advanced economies continue to face challenging conditions, including policies to contain healthcare spending and tighter approval standards」
The company reiterates the challenging environment in advanced economies resulting from healthcare spending controls and tighter approval standards. - FY2017-Q2RestatedAnnual report
「Although advanced economies continue to face challenging conditions, including policies to contain healthcare spending and tighter approval standards」
The company reiterates the challenging environment in advanced economies resulting from healthcare spending controls and tighter approval standards. - FY2017-Q1RestatedAnnual report
「Although advanced economies continue to face challenging conditions, including policies to contain healthcare spending and tighter approval standards」
The company continues to describe the challenging environment in advanced economies resulting from healthcare spending controls and tighter approval standards. - FY2016RestatedAnnual report
「As population aging and advances in medical technology drive a sharp increase in healthcare spending, developed countries are introducing healthcare cost-containment policies one after another.」
Indicates that healthcare cost-containment policies are continuing and that the medical device industry remains in a challenging environment both domestically and overseas. - FY2016-Q3First statedAnnual report
「Developed markets continue to face challenging conditions, including policies to contain healthcare spending and tighter approval standards.」
Describes the ongoing external pressures affecting developed markets.